Urgent Market Update: Stock Market Plunges Again.. Crazy Volatility, When Is The Real Bottom? 'This Position' That Must Be Held And Not Broken | CEO Kim Min-soo

[#UrgentMarketUpdate] Stock Market Plunges Again.. Crazy Volatility, When Is The Real Bottom? 'This Position' That Must Be Held And Not Broken | CEO Kim Min-soo
Watch on YouTube ↗  |  July 24, 2026 at 05:30  |  26:25  |  815 Money Talk (815머니톡)
Speakers
Kim Min-soo — CEO

Summary

The video analyzes the severe KOSPI/KOSDAQ sell-off, discusses critical technical support at 6,800 and trend resistance at 7,300–7,400 for the KOSPI, and examines macro headwinds including oil prices, U.S. yields, and Trump tariff policies. The guest CEO Kim Min-soo highlights Samsung Biologics as a defensive stronghold, watches Hyundai Motor for possible tariff relief, and flags Hanmi Pharm's improving supply-demand. Overall, the market is under pressure from leverage liquidations and credit contraction, with a cautious near-term outlook.

  • KOSPI breaks 6,800 support amid extreme volatility; must reclaim that level to see short-term stabilization.
  • Trend change for KOSPI requires breaking and settling above 7,300–7,400 resistance.
  • Macro factors—rising oil, U.S. 10-year yield at 4.7%, Trump tariff threats—are crushing risk assets.
  • Leverage and credit liquidations are amplifying downside, with retail investors lacking buying power.
  • Samsung Biologics posts strong 1H earnings and acts as a defensive anchor for the index.
  • Hyundai Motor sold off aggressively on tariff fears but could rebound if Korea-U.S. negotiations progress.
  • Hanmi Pharm attracting improved supply-demand ahead of potential performance-driven rally.
  • Overall, sentiment remains fragile; relief rallies depend on macro pivots or policy signals.
Ideas
KOSPI must reclaim 6,800 to stabilize.
KOSPI broke the critical 6,800 support level, showing extreme weakness. To stabilize, it must reclaim 6,800 by the close and eventually break above the downtrend resistance around 7,300–7,400 to achieve a trend reversal.
Hyundai Motor could bounce on tariff relief.
Hyundai Motor is heavily sold off on Trump tariff fears, but upcoming US-Korea meetings on energy and shipbuilding investments could bring tariff negotiation progress and a potential relief rally.
Samsung Biologics strong earnings, defensive play.
Samsung Biologics delivered strong first-half earnings (1 trillion won operating profit). It is effectively a solid manufacturing company, not a speculative biotech, and is holding up the KOSPI index, serving as a defensive holding amid market turmoil.
Hanmi Pharm may rally on good results.
Hanmi Pharm shows improving supply-demand dynamics and could stage a rally when upcoming performance results are announced.
Up Next

This 815 Money Talk (815머니톡) video, published July 24, 2026, features Kim Min-soo discussing EWY, 005380.KS, 207940.KS, 128940.KS. 4 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Kim Min-soo  · Tickers: EWY, 005380.KS, 207940.KS, 128940.KS